US Patent 11787785 Pyrazolopyridine derivatives and uses thereof
Patent 11787785 was granted and assigned to Novartis on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+30 properties)
Article (+400 characters)
US Patent 11787785 Pyrazolopyridine derivatives and uses thereof
Article
Patent abstract
The present disclosure relates to compounds of formula (I) and pharmaceutical compositions and their use in reducing Widely Interspaced Zinc Finger Motifs (WIZ) expression levels, or inducing fetal hemoglobin (HbF) expression, and in the treatment of inherited blood disorders (e.g., hemoglobinopathies, e.g., beta-hemoglobinopathies), such as sickle cell disease and beta-thalassemia.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew W. Patterson
Artiom Cernijenko
Gary O'Brien
Hasnain Ahmed Malik
James R. Manning
Janetta Dewhurst
Jennifer Stroka Cobb
John Ryan Kerrigan
Matthew James Hesse
Natalie Alysia Dales
Noel Marie-France Thomsen
Pamela Y F Ting
Rama Jain
Simone Bonazzi
Date of Patent
October 17, 2023
Patent Application Number
17693759
Date Filed
March 14, 2022
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11787785 Pyrazolopyridine derivatives and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
